Stock markets struggle as antiviral drug hopes fade
Stock markets struggle as antiviral drug hopes fade

London (AFP) – Stock markets struggled on Friday as hopes of quickly finding a treatment for coronavirus were dashed, analysts said, and more crushing economic data delivered a body blow to confidence.Reports said initial trials of the remdesivir coronavirus drug being developed by Gilead Sciences had flopped.Investors were “reacting badly” to the information, Oanda analyst Craig Erlam said.”This was a ray of hope earlier this week and already we’re learning the pitfalls of getting too excited about these cures at the early stages of testing,” Erlam told AFP.Key European markets were all lower…

Read More

HEDGE accordingly